e-learning
resources
Amsterdam 2011
Monday, 26.09.2011
Biomarkers and other new methods for lung cancer
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Evaluation of IL-6 level in serum and bronchoalveolar lavage fluid of patients with non-small cell lung cancer (NSCLC)
M. Petrovic, N. Ilic, Z. Lazic, I. Cekerevac, L. Novkovic, G. Kostic, V. Cupurdija (Kragujevac, Republic Of Serbia)
Source:
Annual Congress 2011 - Biomarkers and other new methods for lung cancer
Session:
Biomarkers and other new methods for lung cancer
Session type:
Thematic Poster Session
Number:
2798
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Petrovic, N. Ilic, Z. Lazic, I. Cekerevac, L. Novkovic, G. Kostic, V. Cupurdija (Kragujevac, Republic Of Serbia). Evaluation of IL-6 level in serum and bronchoalveolar lavage fluid of patients with non-small cell lung cancer (NSCLC). Eur Respir J 2011; 38: Suppl. 55, 2798
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: ICU admission of lung cancer patients – Is COVID-19 a game-changer?
Surgical vs non-surgical treatment of early stage non-small cell lung cancer: here's the fight
N3 hilar sampling decision in the staging of mediastinal lung cancer
Related content which might interest you:
Evaluation of IL-10 level in serum and bronchoalveolar lavage fluid of patients with non-small cell lung cancer (NSCLC)
Source: Annual Congress 2013 –Prognostic factors and subtyping of lung cancer
Year: 2013
TNF-alpha, IL-1 and IL-6 concentration in bronchoalveolar lavage fluid (BALF) of non-small cell lung cancer (NSCLC)
Source: Annual Congress 2013 –New methods for diagnostic workup of lung cancer
Year: 2013
Cytotoxic phenotype of lymphocytes in bronchoalveolar lavage (BAL) of patients with non-small cell lung cancer (NSCLC)
Source: International Congress 2017 – Lung cancer - basic science: the latest results from the bench
Year: 2017
Evaluation of IL-33 level in serum and bronchoalveolar lavage fluid of patients with non-small cell lung cancer (NSCLC)
Source: International Congress 2014 – Biology and pathology of thoracic tumours
Year: 2014
Inflammasome pathway activation in patients with non-small cell lung cancer (NSCLC): A bronchoalveolar lavage fluid study
Source: Annual Congress 2013 –Pathogenesis and risk of lung cancer
Year: 2013
Cytotoxic phenotype of alveolar lymphocytes (AL) in bronchoalveolar lavage fluid (BALF) from non-small cell lung cancer (NSCLC) patients
Source: International Congress 2014 – New mechanisms in the pathogenesis of asthma and other lung diseases
Year: 2014
Matrix metalloproteinase-9 (MMP-9) elevated in serum, but not in bronchial lavage in lung cancer patients
Source: Annual Congress 2013 –New methods for diagnostic workup of lung cancer
Year: 2013
Elevated TGF- b1 concentration in bronchoalveolar lavage fluid from patients with primary lung cancer
Source: Eur Respir J 2002; 20: Suppl. 38, 585s
Year: 2002
Concentration of soluble intercellular adhesion molecule ICAM-1 in bronchoalveolar lavage fluid of patients with non-small cell lung cancer
Source: Eur Respir J 2004; 24: Suppl. 48, 82s
Year: 2004
Overexpression of matrix metalloproteinase-7 (MMP-7) in bronchoalveolar lavage fluid (BALF) of IPF and lung cancer patients
Source: Annual Congress 2011 - Bronchoalveolar lavage and biomarkers in diffuse parenchymal lung disease
Year: 2011
What surgery for which bronchiolo-alveolar carcinoma?
Source: Annual Congress 2006 - Bronchiolo-alveolar carcinoma
Year: 2006
Alvolar lymphocytes (AL) in patients with non-small cell lung cancer (NSCLC). Data from tumor-affected lobe
Source: International Congress 2015 – Connective tissue disorders
Year: 2015
Diagnostic value of tumor markers and cells population in bronchoalveolar lavage in lung cancer
Source: Eur Respir J 2003; 22: Suppl. 45, 37s
Year: 2003
Decreased apoptosis rate of alveolar lymphocytes (AL) in patients with stage I-IIA non-small cell lung cancer (NSCLC)
Source: International Congress 2014 – Biology and pathology of thoracic tumours
Year: 2014
Measurement of trefoil factor peptides in bronchioalveolar lavage (BAL) fluids from patients with COPD or pulmonary cancer
Source: Annual Congress 2009 - COPD: basic science and clinical studies
Year: 2009
Increased expression of WSX1 on alveolar lymphocytes (AL) in patients with early stage non-small cell lung cancer (NSCLC). Preliminary report
Source: International Congress 2014 – Biology and pathology of thoracic tumours
Year: 2014
Serum levels of interleukin 8 and plasma levels of osteopontin in patients with non-small cell lung cancer during chemotherapy
Source: Annual Congress 2011 - Instructive clinical aspects of lung cancer
Year: 2011
Bronchoalveolar lavage in patients with acute lung toxicity after chemo-radiotherapy for lung cancer
Source: Eur Respir J 2003; 22: Suppl. 45, 29s
Year: 2003
Prognostic value of il-6 and TNF-alfa serum concentration in advanced non-small lung cancer patients
Source: Eur Respir J 2003; 22: Suppl. 45, 251s
Year: 2003
Detection of MAGE-A expression in induced sputum and bronchial lavage fluid of patients with lung cancer
Source: Eur Respir J 2003; 22: Suppl. 45, 362s
Year: 2003
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept